![](/img/cover-not-exists.png)
189PFCγRIIa and FCγRIIIa single nucleotide polymorphisms (SNPs) and cetuximab benefit in the EXCITE trial
Sclafani, F, Gollins, S, Cunningham, D, Hulkki Wilson, S, Kouvelakis, K, Lopes, A, West, N, Quirke, P, Begum, R, Valeri, N, Beare, S, Hughes, L, Gonzalez De Castro, D, Chau, IVolume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx659.046
Date:
November, 2017
File:
PDF, 89 KB
2017